医学
英夫利昔单抗
硫唑嘌呤
托珠单抗
重症监护医学
疾病
甲氨蝶呤
进行性多灶性白质脑病
托法替尼
阿达木单抗
类风湿性关节炎
免疫学
内科学
多发性硬化
作者
Jurgen Sota,Adriana Capuano,Giacomo Emmi,Florenzo Iannone,Luca Cantarini,Gülen Hatemi,Giuseppe Lopalco
标识
DOI:10.1016/j.semarthrit.2023.152206
摘要
Neurologic involvement in Behçet's disease (BD) represents a major cause of disease morbidity and mortality. Early recognition and timely treatment represent crucial aspects that aim at preventing long-term disability. The absence of robust and evidence-based studies further complicates the management of neuro-BD (NBD). In this review we aim at collecting the best available evidence and suggest a treatment algorithm for an optimal and personalized management of NBD.
科研通智能强力驱动
Strongly Powered by AbleSci AI